Albega's website banner

ALBEGA Medical


High-end radio-ligand diagnostics and therapeutics


Meet us at BioEurope 2019 in Hamburg!
ALBEGA Medical is a newly established pharmaceutical company developing novel radiopharmaceuticals in oncology.
Our lead compound is Tetrofosmin (TTF) that we are developing in 3 indications:
  • GLIOTECT - a novel diagnostic for brain tumors
  • GLIOTHER - a novel glioma therapeutics
  • MYOTECT - a myocard diagnostic as a generic to Myoview (GE Healthcare)
Drop us an email to get in touch with us.
Click here to download a short company presentation.
Stacks Image p28_n84

Legal information